Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹16.6 LQualified | L1 | Qualified MSE, MII, Category: General | |
| 2 | L2₹16.6 L+₹5,660.90 (0.34%)Qualified 0 PROP OF M S GULAB MEDICOS NEAR JAGDISH HOTEL LADPURA KOTA RAJASTHAN 324005 | KOTA | RAJASTHAN | 324005 | L2 | Qualified MSE, MII, Category: General | |
| 3 | L3₹18.8 L+₹2.2 L (13.3%)Qualified | L3 | Qualified MSE, MII, Category: General | |
| 4 | Disqualified 226 2 SHAHEED UDHAM SINGH NAGAR JALANDHAR PUNJAB 144001 | JALANDHAR | PUNJAB | 144001 | - | Disqualified MSE, MII, Category: General | |
| 5 | Disqualified | - | Disqualified MSE, MII, Category: General |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
1 Jul 2025, 10:00 amClosed
ACYCLOVIR 3 PERCENTAGE W PER W EYE OINTMENT
AMISULPRIDE 50 MG TAB
AZATHIOPRINE 50 MG TAB
BOSENTAN 62 POINT 5 MG TAB
CHLORTHALIDONE 12 POINT 5 MG TAB
CLONAZEPAM 0 POINT 25 MG TAB
DARIFENACIN 7 POINT 5 MG TAB
DILTIAZEM 90MG SR TAB
ED BIMATOPROST 0 POINT 01 PERCENTAGE
ELASTOPLAST
FEXOFENADINE 120MG TAB
GATIFLOXACIN 0 POINT 3 PERCENTAGE EYE DROP BOTT OF 5 ML ED
HYDROXYUREA 500 MG CAP
INJ RABIPUR VACCINE 1 ML
LEFLUNOMIDE 20 MG TAB
MEBEVERINE 135 MG TAB
MIDODRINE 2 POINT 5 MG TAB
NICORANDIL 5 MG TAB
OMEPRAZOLE 20 MG CAP
PHENOBARBITONE 30 MG TAB
PYRIDOSTIGMINE 60 MG TAB
ROTAHALER
SODIUM VALPROATE ORAL SOL 200MG PER 5ML BOTT OF 100 ML
TACROLIMUS 0 POINT 3 PERCETAGE OINT
TOLVAPTAN 15 MG TAB
VILDAGLIPTIN 50MG TAB
XYLOMETALOLINE HCL 0 POINT 05 PERCENTAGE W PERV NASAL DROPS Bid Number : GEM/2025/B/6325693 Dated : 09-06-2025 Bid Document 1/24
7945768
GEM/2025/B/6325693
Two Packet Bid
ACYCLOVIR 3 PERCENTAGE W PER W EYE OINTMENT
30 days
GURDASPUR
Total value wise evaluation
BOQ
8 documents required · 8 mandatory
3 yrs
₹9 L
₹50 L
60%
Exempted
9 Jun 2025
9 Jun 2025
1 Jul 2025
MEDICINE DEMAND ECHS RE 09
ACYCLOVIR 3 PERCENTAGE W PER W EYE OINTMENT
AMISULPRIDE 50 MG TAB
AZATHIOPRINE 50 MG TAB
BOSENTAN 62 POINT 5 MG TAB
CHLORTHALIDONE 12 POINT 5 MG TAB
CLONAZEPAM 0 POINT 25 MG TAB
DARIFENACIN 7 POINT 5 MG TAB
DILTIAZEM 90MG SR TAB
ED BIMATOPROST 0 POINT 01 PERCENTAGE
FEXOFENADINE 120MG TAB
GATIFLOXACIN 0 POINT 3 PERCENTAGE EYE DROP BOTT OF 5 ML ED
HYDROXYUREA 500 MG CAP
INJ RABIPUR VACCINE 1 ML
LEFLUNOMIDE 20 MG TAB
MEBEVERINE 135 MG TAB
MIDODRINE 2 POINT 5 MG TAB
NICORANDIL 5 MG TAB
OMEPRAZOLE 20 MG CAP
PHENOBARBITONE 30 MG TAB
PYRIDOSTIGMINE 60 MG TAB
SODIUM VALPROATE ORAL SOL 200MG PER 5ML BOTT OF 100 ML
TACROLIMUS 0 POINT 3 PERCETAGE OINT
TOLVAPTAN 15 MG TAB
VILDAGLIPTIN 50MG TAB
XYLOMETALOLINE HCL 0 POINT 05 PERCENTAGE W PERV NASAL DROPS Bid Number : GEM/2025/B/6325693 Dated : 09-06-2025 Bid Document 1/24
ACYCLOVIR 3 PERCENTAGE W PER W EYE OINTMENT
AMISULPRIDE 50 MG TAB
AZATHIOPRINE 50 MG TAB
BOSENTAN 62 POINT 5 MG TAB
CHLORTHALIDONE 12 POINT 5 MG TAB
CLONAZEPAM 0 POINT 25 MG TAB
DARIFENACIN 7 POINT 5 MG TAB
DILTIAZEM 90MG SR TAB
ED BIMATOPROST 0 POINT 01 PERCENTAGE
FEXOFENADINE 120MG TAB
GATIFLOXACIN 0 POINT 3 PERCENTAGE EYE DROP BOTT OF 5 ML ED
HYDROXYUREA 500 MG CAP
INJ RABIPUR VACCINE 1 ML
LEFLUNOMIDE 20 MG TAB
MEBEVERINE 135 MG TAB
MIDODRINE 2 POINT 5 MG TAB
NICORANDIL 5 MG TAB
OMEPRAZOLE 20 MG CAP
PHENOBARBITONE 30 MG TAB
PYRIDOSTIGMINE 60 MG TAB
SODIUM VALPROATE ORAL SOL 200MG PER 5ML BOTT OF 100 ML
TACROLIMUS 0 POINT 3 PERCETAGE OINT
TOLVAPTAN 15 MG TAB
VILDAGLIPTIN 50MG TAB
XYLOMETALOLINE HCL 0 POINT 05 PERCENTAGE W PERV NASAL DROPS
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7945768.pdf
GEM_BID
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
demand_echs_re_09_2025-06-09-17-47-44_d419c1c0454d969fb9aa763275c617d0.pdf
BOQ
boq_re_09_2025-06-09-17-47-44_e655405c34c69a27544dd60b90750a7d.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .